DRL launched four new products in North America during the previous quarter.
Pharma companies gear up for the 'new normal' as they train and align their sales forces for a paradigm shift. GSK leads the charge with staggered return-to-work, others plans yoga sessions and health care webinars for salesperson's family.
Analysts are eyeing bigger launches that will positively impact company's fortunes.
